Popular GLP-1 Weight-Loss Drugs Linked to 30% Lower Breast Cancer Risk
3 Articles
3 Articles
Researchers examine unanticipated benefits of GLP-1 medications
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and Dr. Adam Gilden of the University of Colorado examines what scientists are learning as these medications reach millions of people.
Popular GLP-1 Weight-Loss Drugs Linked to 30% Lower Breast Cancer Risk
New research suggests GLP-1 medications may be associated with a lower likelihood of developing breast cancer. GLP-1 medications have transformed the treatment of obesity and type 2 diabetes, but researchers are increasingly exploring whether their benefits extend far beyond weight loss. Now, a study involving more than 110,000 women suggests these widely used drugs may [...]
Recent research suggests that GLP-1 medications, widely used to treat obesity and type 2 diabetes, may be associated with a significant reduction in the risk of developing breast cancer. The study, which involved more than 110,000 women, was presented at the annual meeting of the American Society of Clinical Oncology (ASCO) and published in JCO Oncology Practice. The research analyzed electronic health records of 111,646 women with a body mass i…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
